Taking stock of the mutations in human SARS-CoV-2 spike proteins: From early days to nearly the end of COVID-19 pandemic.
Human SARS-CoV-2
Invariant residues
Mutations
Sequence analyses
Spike protein
Three-dimensional structure analyses
Journal
Current research in structural biology
ISSN: 2665-928X
Titre abrégé: Curr Res Struct Biol
Pays: Netherlands
ID NLM: 101767537
Informations de publication
Date de publication:
2023
2023
Historique:
received:
10
09
2023
accepted:
02
10
2023
medline:
16
10
2023
pubmed:
16
10
2023
entrez:
16
10
2023
Statut:
epublish
Résumé
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causative agent of the coronavirus disease-2019 (COVID-19) has resulted in several deaths and severe economic losses throughout the world. The spike protein in the virus binds to the human ACE-2 receptor in order to mediate virus-host interactions required for the viral transmission. Since first report of the SARS-CoV-2 sequence during December 2019 from patient infected with the virus in Wuhan, China, the virus has undergone rapid changes leading to mutations comprising substitutions, deletions and insertions in the sequence resulting in several variants of the virus that were more virulent and transmissible or less virulent but highly transmissible. The timely intervention with COVID-19 vaccines proved to be effective in controlling the number of infections. However, rapid mutations in the virus led to the lowering of vaccine efficacies being administered to people. In May 2023, the World Health Organization declared COVID-19 was not a public health emergency of international concern anymore. In order to take stock of mutations in the virus from early days to nearly end of COVID-19 pandemic, sequence analyses of the SARS-CoV-2 spike proteins available in the NCBI Virus database was carried out. The mutations and invariant residues in the SARS-CoV-2 spike protein sequences relative to the reference sequence were analysed. The location of the invariant residues and residues at interface of the protein chains in the spike protein trimer complex structure were examined. A total of 111,298 non-redundant SARS-CoV-2 spike protein sequences representing 2,345,585 spike proteins in the NCBI Virus database showed mutations at 1252 of the 1273 positions in the amino acid sequence. The mutations represented 6129 different mutation types in the sequences analysed. Besides, some sequences also contained insertion mutations. The SARS-CoV-2 spike protein sequences represented 1435 lineages. In addition, several spike protein sequences with mutations whose lineages were either 'not classified' or were 'unclassifiable' indicated the virus could still be evolving.
Identifiants
pubmed: 37841365
doi: 10.1016/j.crstbi.2023.100107
pii: S2665-928X(23)00013-2
pmc: PMC10569959
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100107Informations de copyright
© 2023 Published by Elsevier B.V.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
EClinicalMedicine. 2021 Oct;40:101129
pubmed: 34541481
ACS Cent Sci. 2022 Apr 27;8(4):405-407
pubmed: 35505871
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Arch Microbiol. 2021 Dec 6;204(1):8
pubmed: 34873656
JAMA. 2023 Jan 3;329(1):19-20
pubmed: 36484995
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Cell Host Microbe. 2021 Mar 10;29(3):477-488.e4
pubmed: 33535027
Chaos Solitons Fractals. 2023 Apr;169:113193
pubmed: 36817403
J Med Virol. 2020 Apr;92(4):418-423
pubmed: 31967327
Microbiol Spectr. 2022 Jun 29;10(3):e0178921
pubmed: 35638818
J Biomol Struct Dyn. 2023 Apr;41(6):2368-2381
pubmed: 35109768
Lancet Infect Dis. 2022 Dec;22(12):1652-1654
pubmed: 36075232
Bioinformatics. 2006 Jul 1;22(13):1658-9
pubmed: 16731699
Nucleic Acids Res. 2019 Jul 2;47(W1):W260-W265
pubmed: 31028399
Lancet Reg Health Eur. 2021 Jul;6:100109
pubmed: 33997835
Lancet. 2022 Feb 19;399(10326):757-768
pubmed: 34942102
J Pers Med. 2022 Apr 28;12(5):
pubmed: 35629132
Mol Immunol. 2023 Apr;156:10-19
pubmed: 36857806
Nat Rev Microbiol. 2021 Jul;19(7):409-424
pubmed: 34075212
Lancet Microbe. 2021 Jul;2(7):e283-e284
pubmed: 33846703
Allergy. 2022 Jan;77(1):111-117
pubmed: 34453338
J Mol Graph Model. 2021 Dec;109:108035
pubmed: 34562851
Curr Res Struct Biol. 2022;4:41-50
pubmed: 35156058
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Curr Opin Struct Biol. 2022 Aug;75:102402
pubmed: 35717706
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
Sci Rep. 2023 Jun 21;13(1):10053
pubmed: 37344512
Intensive Care Med. 2020 Apr;46(4):586-590
pubmed: 32125455
Sci Adv. 2021 Jan 1;7(1):
pubmed: 33277323
Curr Opin Pulm Med. 2022 May 1;28(3):180-191
pubmed: 35200162
Lancet Microbe. 2022 Feb;3(2):e91
pubmed: 34849495
Clin Infect Dis. 2022 Aug 24;75(1):e715-e725
pubmed: 34922338
ACS Infect Dis. 2022 Sep 9;8(9):1758-1814
pubmed: 35940589
Viruses. 2023 Mar 27;15(4):
pubmed: 37112836
Science. 2021 Apr 30;372(6541):525-530
pubmed: 33727252
Virus Evol. 2021 Jul 30;7(2):veab064
pubmed: 34527285
Proteins. 2020 Nov;88(11):1387-1393
pubmed: 32543705
Prog Biophys Mol Biol. 2021 May;161:39-53
pubmed: 33137344
PLoS Pathog. 2022 Feb 17;18(2):e1010260
pubmed: 35176090
Life Sci Alliance. 2022 Mar 16;5(7):
pubmed: 35296517
Nature. 2022 Mar;603(7902):700-705
pubmed: 35104835
Glycobiology. 2020 Dec 9;30(12):981-988
pubmed: 32363391
EBioMedicine. 2021 Dec;74:103712
pubmed: 34839261
PLoS Biol. 2018 Aug 13;16(8):e3000003
pubmed: 30102691
Cell. 2020 Sep 3;182(5):1284-1294.e9
pubmed: 32730807
Signal Transduct Target Ther. 2021 Nov 15;6(1):396
pubmed: 34782609
Nat Rev Microbiol. 2023 Mar;21(3):162-177
pubmed: 36653446
Lancet Infect Dis. 2021 Aug;21(8):1070
pubmed: 34022142
Nature. 2022 Jul;607(7917):119-127
pubmed: 35576972
Proteins. 2021 May;89(5):569-576
pubmed: 33423311
ACS Cent Sci. 2020 Nov 25;6(11):2046-2052
pubmed: 33269329
Cell Host Microbe. 2021 Apr 14;29(4):508-515
pubmed: 33789086
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508